Gelated microvesicle–mediated delivery of mesenchymal stem cell mitochondria for the treatment of myocardial infarction
Proceedings of the National Academy of Sciences · 08.07.2025 · 122 (27)
DOI: 10.1073/pnas.2424529122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025-07. Verfasst von Qi Chu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, People's Repub…. Hauptthemen laut MEDLINE: Myocardial Infarction, Mesenchymal Stem Cells, Mitochondria, Cell-Derived Microparticles. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs), Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Mitochondrial dysfunction is closely linked to cardiomyocyte injury following myocardial infarction (MI). While mitochondrial transplantation is a promising therapeutic strategy, challenges remain in maintaining mitochondrial structural integrity, enhancing delivery efficiency, and increasing the mitochondrial supply. Herein, we developed a gelated microvesicle–based mitochondria delivery system (Mito@Microgels) for transplanting mesenchymal stem cell mitochondria, addressing the aforementioned issues. Further decoration of phosphatidylserine on the surface of Mito@Microgels boosted cellular uptake efficiency by cardiomyocytes. These Mito@Microgels effectively deliver active mitochondria to cardiomyocytes, improving the mitochondrial network architecture and function and consequently reducing the cellular injury induced by oxidative stress. Moreover, Mito@Microgels attenuated the inflammatory phenotype of macrophages, helping resolve excessive local inflammation. In vivo animal studies using a rat MI model further validated the therapeutic efficacy of the Mito@Microgels, as evidenced by improved myocardial function, prevention of infarcted left ventricular wall thinning, and increased cardiomyocyte survival. Our study introduces an efficient mitochondrial delivery strategy with significant potential for cardiac repair post-MI and other mitochondria-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou 511442, People's Republic of China.
- National Engineering Research Center for Tissue Restoration and Reconstruction and Innovation Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou 510006, People's Republic o…
- Laboratory of Biomedical Engineering of Guangdong Province, South China University of Technology, Guangzhou 510006, People's Republic of China.
ORCID-Profile: Xiaoling Fu
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- MOST | National Key Research and Development Program of China (NKPs)
- Guangdong Basic and Applied Basic Research Foundation
Zitieren
APA
Chu, Q., He, D., Xie, W., Li, S., Dong, Z., & Fu, X. (2025). Gelated microvesicle–mediated delivery of mesenchymal stem cell mitochondria for the treatment of myocardial infarction. Proceedings of the National Academy of Sciences, 122(27). https://doi.org/10.1073/pnas.2424529122
Vancouver
Chu Q, He D, Xie W, Li S, Dong Z, Fu X. Gelated microvesicle–mediated delivery of mesenchymal stem cell mitochondria for the treatment of myocardial infarction. Proceedings of the National Academy of Sciences. 2025;122(27). doi:10.1073/pnas.2424529122
BibTeX
@article{Chu2025,
author = {Chu, Qi and He, Dong and Xie, Wenqi and Li, Shichun and Dong, Zixuan and Fu, Xiaoling},
title = {Gelated microvesicle–mediated delivery of mesenchymal stem cell mitochondria for the treatment of myocardial infarction},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
volume = {122},
number = {27},
doi = {10.1073/pnas.2424529122}
}
EUVIMED